A fully integrated gene and cell therapy company focuses on discovering and delivering innovative therapies using a proprietary AAV gene therapy platform, aimed at addressing multiple serious diseases. The company combines expertise in science, technology, and business to advance a diversified pipeline of transformative treatments.